دورية أكاديمية

O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG

التفاصيل البيبلوغرافية
العنوان: O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG
المؤلفون: Wagner, A., Grabsch, H., Mauer, M., Lorenzen, S., Bouché, O., Thuss-Patience, P., Elme, A., Moehler, M., Romario, U. Fumagalli, Kang, Y., Folprecht, G., Martens, U., Guzmán, M. Galán, Ducreux, M., García, M. Díez, Piessen, G., Collienne, M., Lordick, F.
المصدر: In Annals of Oncology June 2023 34 Supplement 1:S182-S182
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.04.020